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Koprowski ﬁrst emerged in the late 1940s and early 1950s as one
of the giants of virology. With scientiﬁc focus on a vaccine for
poliomyelitis, Sabin and Koprowski worked independently to
develop an attenuated polio vaccine and Salk a killed one.
Koprowski began this work in 1944 with Cox at Lederle Labora-
tories. Their Type II attenuated oral vaccine was the ﬁrst one used
in children in 1950–1951, revealing no side-effects and good
antibody responses. Driven by this ﬁnding, over the next few
years Type I and III polioviruses were attenuated, and more than
1000 children vaccinated orally with 91% showing signiﬁcant
antibody responses to all three poliomyelitis virus types. In 1958
mass immunizations occurred in Zaire for 250,000 children and
nine million children in Poland. An interesting story is the
selection of Sabin's vaccine over that of Koprowski's by the U.S.
Public Health Service Committee, the details can be visited in The
History of Poliomyelitis by J.R. Paul Jr. (New Haven, CT, 1971), “AVisit
to Ancient History” by H. Koprowski in Microbe Hunters—Then and
Now (Bloomington, IL, 1996), and his biography Listen to the Music:
The Life of Hilary Koprowski by Roger Vaughan. By 1957 Koprowski
arrived at The Wistar Institute in Philadelphia, where he served as
its Director for 35 years, transforming the Wistar into an Institute
for Scientiﬁc Research. By opening the Institute to gifted trainee'sand scientists including those from Europe, he created a world-
class Research Institute. During his tenure at the Wistar,
Koprowski was at the forefront of virology with his research team
making important observations with rabies virus that led to his
development of a new vaccine for humans and animals, including
mass vaccination of wildlife using bait spiked with the vaccine. He
did pioneering work in the area of hyperallergic and chronic
measles virus infection, in cell fusion, studies of SV40 and the
susceptibility of fertilized and unfertilized eggs to oncogenic
viruses. Koprowski also developed human monoclonal antibodies
including the ﬁrst functional monoclonals against colorectal can-
cer and rabies. In addition to his scientiﬁc and administrative
strengths, Hilary Koprowski was a man for all seasons, a true
Renaissance Man. An accomplished classical pianist and composer,
Koprowski received the Nicolaus Copernicus Medal of the Polish
Academy of Sciences. He was also featured on Polish television
playing Chopin. At his 90th birthday party, he and his guests were
serenaded by an ensemble from the Philadelphia Orchestra that
played a concerto he composed, “Tutto Il Mondo.”
How Koprowski came to the United States is a tale made for
Hollywood. Born in Warsaw, Poland, Koprowski graduated from
the Faculty of Medicine at Warsaw University and the Warsaw
Conservatory of Music. He traveled to Rome where his studies at
Santa Cecilia Conservatory of Music were interrupted in 1939 with
the onset of World War II. Forced to ﬂee from Nazi Europe, as he
related, in multiple disguises and traveling by routes separate from
his wife, Irena, he eventually reached Portugal, reunited with his
wife, and traveled by boat to Rio de Janeiro, Brazil. There he met a
fellow Pole who told him of the Yellow Fever Research Service
sponsored by the Rockefeller Foundation and the Ministry of
Education of Brazil. Retiring to a library and after immersing
himself in the past and current literature on yellow fever, he
applied to the American epidemiologist/virologist Ed Lanette of
the Yellow Fever Commission for a job and was hired as a research
associate from 1940 to 1944. It was over that time he became
aware and studied the process of attenuation of yellow fever virus
for how to make a successful vaccine as developed by Max Theiler.
By 1944, with Lanette's assistance, Koprowski came to the United
States as a research associate in the Section of Viral and Rickettsial
Research at Lederle Laboratories where he worked with Harold
Cox. Koprowski stayed at Lederle from 1946 as the Assistant
Director of the Section of Viral and Rickettsial Research until
becoming Director of The Wistar Institute in 1957. Over a research
life his scientiﬁc accomplishment lead to election to the National
Academy of Sciences, election as a foreign member to Yugoslav,
Polish, Russian, and Finnish Academies. Koprowski was recipient
of many honors and prizes including the Order of the Lion from
the King of Belgium, the French Order of Merit for Research and
Invention, the Legion d'Honneur from the French government,
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of the Order of the Lion of Finland by the President of Finland.
Lastly, Koprowski's interest and work on vaccination came full-
circle during the last decade of his life, as he continued working up
until a few months before his illness. Over that time he directed
his efforts towards the development of biomedical products in
plants. He succeeded in producing rabies vaccine in spinach and
antibodies against rabies and cancer antigens in tobacco. Prior to
his death he was involved in clinical trials with hepatitis B vaccine
expressed in lettuce. Thus his concept of universal vaccinationthrough eatable plants. Those who were fortunate to know Hilary
will miss him.Michael B.A. Oldstone n
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